Latest Breaking News On - Steve scala - Page 23 : comparemela.com

By Syndicated Content May 27, 2021 | 5:36 PM Bristol Myers Squibb said on Thursday the U.S. Food and Drug Administration approved its oral drug Zeposia to treat adults with ulcerative colitis, a chronic inflammatory bowel disease. Bristol Myers gained the drug, approved last year for treating multiple sclerosis patients, in 2019 through its $74 billion buyout of Celgene. Zeposia last year June met the main goals of a late-stage study, showing patients who took it achieved clinical remission of ulcerative colitis when compared to placebo. (https://reut.rs/2SA6RFe) Cowen analyst Steve Scala, in a note on May 23, estimated Zeposia sales of $150 million in 2021, $400 million in 2022 and $1 billion in 2025.

Steve scalaAmruta khandekarShinjini ganguliBristol myersTakeda pharmaceutical coEuropean medicines agencyDrug administrationBristol myers squibbஸ்டீவ் ஸ்காலஅம்ருதா கண்டெகர்ஷின்ஜினி கங்குலிபிரிஸ்டல் மைஸ்டாகேடா மருந்து இணைபிரிஸ்டல் மைஸ் ஸ்க்விப்ப்